Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE‐Cog Field Trial
Emma Hooper(University of Manchester), Iracema Leroi(Trinity College Dublin), Susana Montecelo(Essilor (France)), Piers Dawes(The University of Queensland), Hannah Hussain(Manchester Academic Health Science Centre), Mark Hann(Manchester Academic Health Science Centre), Catherine Helmer(Inserm), Jemma Regan(Manchester Academic Health Science Centre), Elizabeth Camacho(Manchester Academic Health Science Centre), Anna Pavlina Charalambous(European University Cyprus), Ines Himmelsbach(Catholic University of Applied Sciences Freiburg), David Reeves(Manchester Academic Health Science Centre), Harvey B. Abrams(University of South Florida), Rachel Elliott(University of Nottingham), Zoë Simkin(University of Manchester), Chryssoula Thodi(European University Cyprus), Sue Falkingham(Starkey Hearing Technologies (United States)), Fofi Constantinidou, Fidéline Collin(Université de Bordeaux), Lucas Wolski(Catholic University of Applied Sciences Freiburg), Sarah Marié(Essilor (France)), Éric Frison(Université de Bordeaux)
Cited by 29
Related Papers
The changing prevalence and incidence of dementia over time — current evidence
|Nature Reviews Neurology|2017|773
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Health status of UK care home residents: a cohort study
|Age and Ageing|2013|421
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
|JAMA Internal Medicine|2016|405
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380